Big Problems of Tiny Filters: Nursing Guidance in the Treatment Journey of Glomerular Diseases

Yıl 2025, Cilt: 8 Sayı: 3, 124 - 131, 15.05.2025

Ahmet Ceviz , Gürkan Özden

https://doi.org/10.19127/bshealthscience.1569176

Öz

The basic elements of nursing care in glomerular diseases include symptom management and monitoring, medication management and compliance, patient education and self-management, psychosocial support and care coordination. It is important to monitor fluid and electrolyte balance, control blood pressure, take medications regularly and manage side effects. Nurses encourage patients to maintain a healthy lifestyle and provide psychosocial support. The most common glomerular diseases include glomerulonephritis, glomerulosclerosis and diabetic nephropathy. The treatment and care of each glomerular disease is based on principles such as symptom management, drug therapy, dietary compliance, blood pressure control and psychosocial support. Nurses encourage patient compliance with treatment plans, monitor and manage symptoms, prevent complications, and coordinate care with a multidisciplinary approach. Glomerular diseases result from complex pathological processes. Multiple drugs may be used in this process. The care of patients with infection-associated glomerular disease requires supportive treatment to increase compliance with medical intervention. Nurses help patients improve their compliance with medical treatments, manage symptoms and develop skills to cope with the disease. Patient education and ongoing support can improve health outcomes and enhance quality of life.

Anahtar Kelimeler

Kidney functions, Kidney diseases, Glomerular diseases, Nursing interventions

Minik Filtrelerin Büyük Sorunları: Glomerüler Hastalıkların Tedavi Yolculuğunda Hemşirelik Rehberliği

Öz

Glomerüler hastalıklarda hemşirelik bakımının temel unsurları, semptom yönetimi ve izleme, ilaç yönetimi ve uyum, hasta eğitimi ve öz yönetim, psikososyal destek ve bakım koordinasyonunu içermektedir. Hastaların sıvı ve elektrolit dengesinin izlenmesi, kan basıncının kontrolü, ilaçların düzenli alınması ve yan etkilerin yönetilmesi önemlidir. Hemşireler, hastaları sağlıklı bir yaşam tarzı sürdürmeye teşvik etmekle birlikte psikososyal destek sağlamaktadır. En sık karşılaşılan glomerüler hastalıklar arasında glomerülonefrit, glomerüloskleroz ve diyabetik nefropati yer almaktadır. Her glomerüler hastalığın tedavisi ve bakımı, semptom yönetimi, ilaç tedavisi, diyete uyum, kan basıncı kontrolü ve psikososyal destek gibi prensiplere dayanmaktadır. Hemşireler, hastaların tedavi planlarına uyumlarını teşvik etmekte, semptomlarını izlemekte ve yönetmektedir. Ayrıca, komplikasyonları önlemekte ve multidisipliner bir yaklaşımla bakım koordinasyonunu sağlamaktadır. Glomerüler hastalıklar kompleks patolojik süreçlerden kaynaklanmaktadır. Bu süreçte birden fazla ilaç kullanılabilmektedir. Enfeksiyonla ilişkili glomerüler hastalığı olan hastaların bakımı, tıbbi müdahaleye uyumu artırmak için destekleyici tedaviyi gerektirmektedir. Hemşireler, hastaların tıbbi tedavilere uyumunu artırmak, semptomları yönetmek ve hastalıkla başa çıkma becerilerini geliştirmelerine yardımcı olmaktadır. Hasta eğitimi ve sürekli destek, sağlık sonuçlarını iyileştirebilir ve yaşam kalitesini artırabilir.

Anahtar Kelimeler

Böbrek fonksiyonları, Böbrek hastalıkları, Glomerüler hastalıklar, Hemşirelik müdahaleleri

Kaynakça

• Abuzeid MAM, Ali AB, Mostafa FMM. 2019. Clinical audit on management of acute poststreptococcal glomerulonephritis in children admitted to Assiut University Children Hospital. Egypt J Hosp Med, 74(1): 80-86. https://doi.org/10.21608/EJHM.2019.22467
• Anjos LMM, Marcondes MB, Lima MF, Mondelli AL, Okoshi MP. 2014. Streptococcal acute pharyngitis. Rev Soc Bras Med Trop, 47(4): 409-413. https://doi.org/10.1590/0037-8682-0265-2013
• Bertola EA, Simonetti GD, Del Giorno R, Giannini O, Fossali EF, Meoli M, Bianchetti MG, Terziroli Beretta-Piccoli B, Milani GP. 2019. Extrarenal ımmune-mediated disorders linked with acute poststreptococcal glomerulonephritis: A systematic review. Clin Rev Allergy Immunol, 57(2): 294-302. https://doi.org/10.1007/s12016-019-08761-w
• Bonner A, Douglas B, Brown L, Harvie B, Lucas A, Tomlins M, Gillespie K. 2023. Understanding the practice patterns of nephrology nurse practitioners in Australia. J Ren Care, 49(4): 278-287. https://doi.org/10.1111/JORC.12444
• Brown S, Elliott J, Francey T, Polzin D, Vaden S. 2013. Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med, 27(s1): 27-43. https://doi.org/10.1111/jvim.12230
• Chen CC, Chen Y, Liu X, Wen Y, Ma DY, Huang YY, Pu L, Diao YS, Yang K. 2016. The efficacy of a nurse-led disease management program in ımproving the quality of life for patients with chronic kidney disease: A meta-analysis. PLoS One, 11(5): e0155890. https://doi.org/10.1371/JOURNAL.PONE.0155890
• Chen X, Chen Y, Shi K, Lv Y, Tong H, Zhao G, Chen C, Chen B, Li D, Lu Z. 2017. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy. Sci Rep, 7(1): 11468. https://doi.org/10.1038/s41598-017-11838-1
• Di Tu, Jin J, Hu X, Ren Y, Zhao L, He Q. 2020. Curcumin improves the renal autophagy in rat experimental membranous nephropathy via regulating the PI3K/AKT/mTOR and Nrf2/HO-1 signaling pathways. Biomed Res Int, 2020: 7069052: 1-12. https://doi.org/10.1155/2020/7069052
• Dick J, Gan PY, Ford SL, Odobasic D, Alikhan MA, Loosen SH, Hall P, Westhorpe CL, Li A, Ooi JD, Woodruff TM, Mackay CR, Kitching AR, Hickey MJ, Holdsworth SR. 2018. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis. Kidney Int, 93(3): 615-625. https://doi.org/10.1016/j.kint.2017.09.018
• ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Gibbons CH, Giurini JM, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Sun JK, Gabbay RA, American Diabetes Association. 2023. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes—2023. Diabetes Care, 46(1): 203-215. https://doi.org/10.2337/dc23-S012
• Farghaly M, Badran A, Keraa K. 2021. Assessing knowledge, practices, use and raising awareness of antibiotics and antibiotic resistance among dental patients before and after educational sessions. Braz Dent J, 24(4): 1-10. https://doi.org/10.14295/bds.2021.v24i4.2646
• Floege J, Amann K. 2016. Primary glomerulonephritides. The Lancet, 387(10032): 2036-2048. https://doi.org/10.1016/S0140-6736(16)00272-5
• Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH. 2019. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 95(2): 268-280. https://doi.org/10.1016/j.kint.2018.10.018
• Hasan AA, Hocher B. 2017. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy. J Mol Endocrinol, 59(1): 1-10. https://doi.org/10.1530/JME-17-0005
• Heta S, Robo I. 2018. The side effects of the most commonly used group of antibiotics in periodontal treatments. Med Sci, 6(1): 6. https://doi.org/10.3390/medsci6010006
• Hogan J, Mohan P, Appel GB. 2014. Diagnostic tests and treatment options in glomerular disease: 2014 update. Am J Kidney Dis, 63(4): 656-666. https://doi.org/10.1053/j.ajkd.2013.09.019
• Kunze KN, Cohn MR, Wakefield C, Hamati F, LaPrade RF, Forsythe B, Yanke AB, Chahla J. 2019. YouTube as a source of ınformation about the posterior cruciate ligament: A content-quality and reliability analysis. Arthrosc Sports Med Rehabil, 1(2): 109-114. https://doi.org/10.1016/j.asmr.2019.09.003
• Lucena AF, Magro CZ, Proença MC, Pires AUB, Moraes VM, Aliti GB. 2018. Validação de intervenções e atividades de enfermagem para pacientes em terapia hemodialítica. Rev Gaucha Enferm, 38(3): e66789. https://doi.org/10.1590/1983-1447.2017.03.66789
• Ma G, Luo A, Shen Z, Duan Y, Shi S, Zhong Z. 2020. The status of medication literacy and associated factors of hypertensive patients in China: a cross-sectional study. Intern Emerg Med, 15(3): 409-419. https://doi.org/10.1007/s11739-019-02187-0
• Marcus N, Stergiopoulos V. 2022. Re-examining mental health crisis intervention: A rapid review comparing outcomes across police, co-responder and non-police models. Health Soc Care Community, 30(5): 1665-1679. https://doi.org/10.1111/HSC.13731
• Mariani LH, Pendergraft WF, Kretzler M. 2016. Defining glomerular disease in mechanistic terms: Implementing an integrative biology approach in nephrology. Clin J Am Soc Nephrol, 11(11): 2054-2060. https://doi.org/10.2215/CJN.13651215
• McAdoo SP, Pusey CD. 2017. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol, 12(7): 1162-1172. https://doi.org/10.2215/CJN.01380217
• Murali KM, Mullan J, Roodenrys S, Hassan HC, Lambert K, Lonergan M. 2019. Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials. PLoS One, 14(1): e0211479. https://doi.org/10.1371/journal.pone.0211479
• Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A, Stokes MB, Markowitz GS, D'Agati VD. 2011. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol, 22(1): 187-195. https://doi.org/10.1681/ASN.2010060611
• Nasr SH, Radhakrishnan J, D’Agati VD. 2013. Bacterial infection-related glomerulonephritis in adults. Kidney Int, 83(5): 792-803. https://doi.org/10.1038/KI.2012.407
• Ong LT. 2022. Management and outcomes of acute post-streptococcal glomerulonephritis in children. World J Nephrol, 11(5): 139-145. https://doi.org/10.5527/wjn.v11.i5.139
• Orr P, Shank BC, Hickson S, Cooke J. 2018. Clinical Management of Glomerular Diseases. Nurs Clin North Am, 53(4): 551-567. https://doi.org/10.1016/j.cnur.2018.07.006
• Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. 2021. Glomerulonephritis in AKI: From pathogenesis to therapeutic intervention. Front Med, (7): 582272. https://doi.org/10.3389/fmed.2020.582272
• Raina R, Wang J, Sharma A, Chakraborty R. 2020. Extracorporeal therapies in the treatment of focal segmental glomerulosclerosis. Blood Purif, 49(5): 513-523. https://doi.org/10.1159/000506277
• Rajchgot T, Thomas SC, Wang JC, Ahmadi M, Balood M, Crosson T, Dias JP, Couture R, Claing A, Talbot S. 2019. Neurons and microglia; A sickly-sweet duo in diabetic pain neuropathy. Front Neurosci, 13: 25. https://doi.org/10.3389/fnins.2019.00025
• Reid L, Baxter F, Forbes S. 2021. Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes. Diabet Med, 38(7): e14570. https://doi.org/10.1111/dme.14570
• Rosenberg AZ, Kopp JB. 2017. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol, 12(3): 502-517. https://doi.org/10.2215/CJN.05960616
• Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mejía-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J. 2021. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int, 100(4): 753-779. https://doi.org/10.1016/j.kint.2021.05.015
• Ruggenenti P, Fervenza FC, Remuzzi G. 2017. Treatment of membranous nephropathy: Time for a paradigm shift. Nat Rev Nephrol, 13(9): 563-579. https://doi.org/10.1038/nrneph.2017.92
• Seo E, Kang H, Oh Y, Jun HS. 2017. Psoralea corylifolia L. seed extract attenuates diabetic nephropathy by ınhibiting renal fibrosis and apoptosis in streptozotocin-ınduced diabetic mice. Nutrients, 9(8): 828. https://doi.org/10.3390/nu9080828
• Shabaka A, Tato Ribera A, Fernández-Juárez G. 2020. Focal segmental glomerulosclerosis: State-of-the-art and clinical perspective. Nephron, 144(9): 413-427. https://doi.org/:10.1159/000508099
• Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R. 2011. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med, 364(7): 616-626. https://doi.org/10.1056/NEJMoa1009742
• Stavropoulou A, Rovithis M, Grammatikopoulou MG, Kyriakidi K, Pylarinou A, Markaki AG. 2020. Exploring patients’ experiences after chronic kidney disease diagnosis: A qualitative study. Nephrol Nurs J, 47(1): 67-98. https://doi.org/10.37526/1526-744X.2020.41.1.67
• Suresh V, Stillman IE, Campbell KN, Meliambro K. 2024. Focal segmental glomerulosclerosis. Adv Kidney Dis Health, 31(4): 275-289. https://doi.org/10.1053/J.AKDH.2024.03.009
• Sweetwyne MT, Pippin JW, Eng DG, Hudkins KL, Chiao YA, Campbell MD, Marcinek DJ, Alpers CE, Szeto HH, Rabinovitch PS, Shankland SJ. 2017. The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age. Kidney Int, 91(5): 1126-1145. https://doi.org/10.1016/j.kint.2016.10.036
• Tai YYS, Foo YH, Ignacio J. 2024. Effectiveness of educational interventions for nurses caring for patients with chronic kidney disease in improving nurse outcomes: A systematic review. J Clin Nurs, 33(3): 951-981. https://doi.org/10.1111/JOCN.16929
• Thirsk LM, Moore SG, Keyko K. 2014. Influences on clinical reasoning in family and psychosocial interventions in nursing practice with patients and their families living with chronic kidney disease. J Adv Nurs, 70(9): 2117-2127. https://doi.org/10.1111/JAN.12370
• Uchida T, Oda T. 2020. Glomerular deposition of nephritis-associated plasmin receptor (NAPlr) and related plasmin activity: Key diagnostic biomarkers of bacterial ınfection-related glomerulonephritis. Int J Mol Sci, 21(7): 2595. https://doi.org/10.3390/ijms21072595
• Varghese RT, Jialal I, Doerr C. 2023. Diabetic nephropathy (Nursing). URL: https://www.ncbi.nlm.nih.gov/books/NBK568691/ (erişim tarihi: 15 Ağustos 2024).
• Wang J, Yue P, Huang J, Xie X, Ling Y, Jia L, Xiong Y, Sun F. 2018a. Nursing intervention on the compliance of hemodialysis patients with end-stage renal disease: A meta-analysis. Blood Purif, 45(1-3): 102-109. https://doi.org/10.1159/000484924
• Wang K, Hu J, Luo T, Wang Y, Yang S, Qing H, Cheng Q, Li Q. 2018b. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: A systematic review and meta-analysis. Kidney Blood Press Res, 43(3): 768-779. https://doi.org/10.1159/000489913
• Wenderfer SE, Gaut JP. 2017. Glomerular diseases in children. Adv Chronic Kidney Dis, 24(6): 364-371. https://doi.org/10.1053/J.ACKD.2017.09.005
• Worthing KA, Lacey JA, Price DJ, McIntyre L, Steer AC, Tong SYC, Davies MR. 2019. Systematic review of group a streptococcal emm types associated with acute post-streptococcal glomerulonephritis. Am J Trop Med Hyg, 100(5): 1066-1070. https://doi.org/10.4269/ajtmh.18-0827